Additional Study Information: This research study uses brain imaging to explore brain activity in healthy individuals as compared topersons with bipolar depression who have received ketamine treatment, an experimentalantidepressant drug. Our goal is to develop new treatments for depression. Participation involves twomagnetic resonance imaging (MRI) scans and clinical assessment (but no ketamine/other medication).Eligible individuals will be compensated up to $200.